| 000 | 01888 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513214649.0 | ||
| 264 | 0 | _c20000914 | |
| 008 | 200009s 0 0 eng d | ||
| 022 | _a0886-1544 | ||
| 024 | 7 |
_a10.1002/1097-0169(200007)46:3<222::AID-CM6>3.0.CO;2-B _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEto, M | |
| 245 | 0 | 0 |
_aInhibition of myosin/moesin phosphatase by expression of the phosphoinhibitor protein CPI-17 alters microfilament organization and retards cell spreading. _h[electronic resource] |
| 260 |
_bCell motility and the cytoskeleton _cJul 2000 |
||
| 300 |
_a222-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aActin Cytoskeleton _xmetabolism |
| 650 | 0 | 4 |
_aActins _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Size _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFibroblasts _xcytology |
| 650 | 0 | 4 |
_aFibronectins _xpharmacology |
| 650 | 0 | 4 |
_aGene Expression _xphysiology |
| 650 | 0 | 4 |
_aMuscle Proteins _xgenetics |
| 650 | 0 | 4 |
_aMyosin Light Chains _xmetabolism |
| 650 | 0 | 4 |
_aMyosin-Light-Chain Kinase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMyosin-Light-Chain Phosphatase |
| 650 | 0 | 4 |
_aPhalloidine _xpharmacology |
| 650 | 0 | 4 |
_aPhosphoprotein Phosphatases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPhosphoproteins _xgenetics |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aPlasmids |
| 650 | 0 | 4 | _aRats |
| 700 | 1 | _aWong, L | |
| 700 | 1 | _aYazawa, M | |
| 700 | 1 | _aBrautigan, D L | |
| 773 | 0 |
_tCell motility and the cytoskeleton _gvol. 46 _gno. 3 _gp. 222-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0169(200007)46:3<222::AID-CM6>3.0.CO;2-B _zAvailable from publisher's website |
| 999 |
_c10863686 _d10863686 |
||